NCT00752141View on ClinicalTrials.gov

Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2008

Conditions
Healthy Volunteers
Interventions
DRUG

oxybutynin chloride immediate-release

capsule containing oxybutynin chloride immediate-release 5 mg tablet administered three times daily, and placebo gel administered once daily

DRUG

oxybutynin chloride topical gel

oxybutynin chloride topical gel applied once daily, and capsule containing placebo tablet administered three times daily

OTHER

placebo

capsule containing placebo tablet administered three times daily, and placebo gel administered once daily

Trial Locations (6)

32751

Maitland

34102

Naples

34471

Ocala

91950

National City

85741-3656

Tucson

30341-4155

Atlanta

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00752141 - Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers | Biotech Hunter | Biotech Hunter